Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal Women
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: celecoxib
Sponsor: University of Kansas Medical Center
Collaborators: National Cancer Institute (NCI)